Front Page
July 5, 2024
Webinar: ASAM Criteria Implementation and Science Based Implementation Strategies (July 17, 12pm PT)
Join the Northwest ATTC at ADAI on July 17, 2023 (12-1pm PT) for their next webinar: ASAM Criteria Implementation and Science Based Implementation Strategies! The collective struggle of healthcare systems to engage in timely and sustained implementation of the ASAM criteria and other EBPs has been well documented. Implementation science helps us to understand the…
June 24, 2024
What’s New in Harm Reduction Research (June 2024)
A review of recently published research on harm reduction topics – June 2024 Need help getting copies of any of these articles? Email Meg Brunner, MLIS (meganw@uw.edu). Free articles have “(open access)” after the titles; all other articles require a subscription to access. FROM LOCAL AUTHORS “I go out of my way to give them…
June 17, 2024
Third Space Toolkit: New Resource from ADAI’s CAAHS Supporting Telehealth for Substance Use Disorders
ADAI’s Center for Advancing Addiction Health Services (CAAHS), working with the Idaho Department of Health and Welfare, recently developed an interactive online toolkit, the Third Space Toolkit: Building Space for Telehealth in Libraries and the Community, to support the addition of “privacy pods” in Idaho public libraries for the purpose of providing private spaces for…
Congratulations to Our ADAI Spring Small Grants Awardees!
What are ADAI Small Grants? ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants Program, which awards funds to UW researchers for pilot studies and developmental research. The scope ranges from pharmacology of drugs to studies of clinical treatment strategies, prevention, and social policy issues….
June 14, 2024
Slides & Recording Available: What’s in the Drug Supply: Updates from the WA State Community Drug Checking Network
Update: This event was held on June 12, 2024. The slides & recording are now available. The WA State Community Drug Checking Network (CDCN) is a partnership of organizations that provide community-level drug checking and harm reduction services. The ADAI Center for Community-Engaged Drug Education, Epidemiology, and Research (CEDEER) provides support including technical assistance and state-level data on…
June 11, 2024
New ADAI Publications on Cannabis and Opioid Policy
Several ADAI researchers have some new publications out recently related to cannabis and opioid policy: State Requirements for Non-Medical Cannabis “Budtenders” Beatriz Carlini, PhD, MPH, Research Associate Professor and Director of ADAI’s Cannabis Education & Research Program, is coauthor of a new paper on State requirements for non-medical US cannabis retail personnel (LoParco C, et…
June 3, 2024
Recording available: Safe Supply: What is it? Do people want it? What impacts could it have?
Update: This event was held on May 30, 2024. Find the recording and slides here. Overdoses and health problems among people who use drugs are increasing. Safe supply models provide a regulated and known dose of opioids to reduce negative health consequences. In this webinar we’ll explore: Presenters:Addie Palayew, MsC, PhDc, & Caleb Banta-Green, PhD, MPH, MSW, UW ADAI…
May 29, 2024
2024 ADAI WA State Legislative Wrap-Up
During the 2024 state legislative session, two bills passed the Washington State Legislature and were signed by the Governor that involved ADAI. Following is a summary of the two bills. 2SHB 2320: An act relating to reducing the public health harms associated with high THC cannabis products ADAI’s Cannabis Education and Research Program’s (CERP) research…
May 23, 2024
Front Lines of the Fentanyl Crisis: Dr. Caleb Banta-Green testifies to U.S. Senate Finance Committee, Fatal Overdose Reduction Act Introduced
ADAI Research Professor, Caleb Banta-Green, PhD, MPH, MSW, Director of the Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER), flew to Washington D.C. this week to testify in front of the U.S. Senate Finance Committee for a special hearing titled “Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and…
May 8, 2024
ADAI in the News – Cannabis Edition
ADAI’s Director, Susan Ferguson, PhD, was recently featured in two news pieces about the U.S. Drug Enforcement Administration’s move toward reclassifying cannabis as a less dangerous drug by lowering it from Schedule I to Schedule III. (What do these terms mean?) In an article for the AP that discusses numerous impacts such a change might…
Previous page Next page
